Thus, our study suggests that the collapsing glomerulopathy phenotype in COVID-19+ risk allele patients may be a consequence of APOL1 induction in podocytes following IFN-γ exposure, rather than direct infection by the virus. The gene discussed is APOL1; the disease is COVID-19.